Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04217551 · ClinicalTrials.gov registry record · NA

Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

A NA study of Cardiac Arrest, Out-Of-Hospital and Hypoxia-Ischemia, Brain, sponsored by University of Michigan.

Active
Registry status
NA
Development phase
1,158
Enrollment target
20
Study locations

NCT04217551 is a NA study of Cardiac Arrest, Out-Of-Hospital and Hypoxia-Ischemia, Brain that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 1,158 participants, below the 1,394-participant average among 5 other Cardiac Arrest, Out-Of-Hospital trials with a reported enrollment target (17% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04217551, a NA study of Cardiac Arrest, Out-Of-Hospital and Hypoxia-Ischemia, Brain, is active but no longer recruiting, sponsored by University of Michigan.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,158 participants
Enrollment target
20
Study locations

Study Summary

A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.

Interventions

  • DEVICE Therapeutic Hypothermia

Study Locations (20)

California

  • Cedars-Sinai Medical Center - Los Angeles
  • Ronald Regan UCLA Medical Center - Los Angeles
  • UC Davis Medical Center - Sacramento
  • UC San Diego Medical Center - Hillcrest - San Diego
  • Zuckerberg San Francisco General Hospital - San Francisco
  • Stanford University Medical Center - Stanford
  • Harbor-UCLA Medical Center - Torrance

Illinois

  • Northwestern Memorial Hospital - Chicago
  • Rush University Medical Center - Chicago
  • University of Illinois-Chicago Hosptial - Chicago
  • University of Chicago Medical Center - Chicago

Colorado

  • University of Colorado Hospital - Aurora
  • Denver Health Medical Center - Denver

Alabama

  • University of Alabama Hospital - Birmingham

Arizona

  • Banner University Medical Center - Tucson

Connecticut

  • Yale New Haven Hospital - New Haven

District of Columbia

  • George Washington University Hospital - Washington D.C.

Florida

  • UF Health Shands Hospital - Gainesville

Trial Details

FieldValue
Enrollment Target 1,158 participants
Start Date 2020-05-18
Est. Completion 2025-09-05
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04217551

The ClinicalTrials.gov registry entry for NCT04217551 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,158 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,394-participant average among 5 other Cardiac Arrest, Out-Of-Hospital trials with a reported enrollment target (17% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cardiac Arrest, Out-Of-Hospital appearing as the primary indexed condition, and to 1 intervention - of which Therapeutic Hypothermia is the first listed.

NCT04217551 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Illinois, Colorado.

Frequently Asked Questions

What is clinical trial NCT04217551 about?

NCT04217551 is a clinical study titled "Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients". A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of card...

What is the current status of trial NCT04217551?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,158 participants. The study started on 2020-05-18. Estimated completion is 2025-09-05.

What conditions does trial NCT04217551 study?

This clinical trial studies the following conditions: Cardiac Arrest, Out-Of-Hospital, Hypoxia-Ischemia, Brain, Hypothermia, Induced.

What interventions are being tested in trial NCT04217551?

The interventions under investigation include: Therapeutic Hypothermia (DEVICE).

Who is sponsoring clinical trial NCT04217551?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04217551 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrest, Out-Of-Hospital

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.